Multiple states said they will resume administering the Johnson & Johnson COVID-19 vaccine after federal health authorities agreed on Friday that the benefits outweigh the risks.
Virginia, Illinois, Massachusetts, Nevada and New York all announced that they will be immediately restarting administration of the J&J vaccine as doses sit on the shelves after the 10-day pause.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) said Friday that the J&J vaccine could be administered again after accepting the recommendation from a CDC panel. The agencies had put a pause on the vaccine April 13.
Federal regulators said Friday they were aware of 15 cases of rare blood clots happening in younger women, including three women who died and seven still in the hospital. However, those cases are out of nearly 8 million shots administered, and the agencies said the benefits of the vaccine outweigh its risks.
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- ‘No other way to spin it’: CNN expert says inflation number ‘positive news’ - December 18, 2025
- Fairfax County freed illegal despite ICE request — now a man is dead - December 18, 2025
- US may be entering moderate moment as voters reject radicalism, poll suggests - December 18, 2025
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
